Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Mahad Omar

DPhil student

Mahad earned a BSc (Hons) in Biomedical Science from Cardiff Metropolitan University, where he received an award for outstanding academic achievement and represented his university at notable events such as the Buckingham Palace Golden Jubilee and Highgrove House. He continued his education in medicine at the University of Southampton, followed by surgical training, during which he joined a biomarker research group at Swansea Bay University Health Board. Under the guidance of Professors A. Evans and K. Morrison, he published in prestigious journals and presented his work at various national and international conferences.

He continued plastic and reconstructive surgical training in the UK, Spain, and South Africa. Mahad is currently involved in the SENTINEL STUDY as a flap retriever and reconstructive surgeon. He regularly participates in the International Microsurgery Club webinar, where he has been invited to present and be a member of the expert panel to contribute to specific reconstructive topics.

His DPhil (PhD) research aims to deepen the understanding of the central nervous system lymphatic system in the context of neurodegenerative diseases. He investigates the interactions between meningeal lymphatic vessels, glymphatic systems, and cerebrospinal fluid (CSF) dynamics in neurodegenerative patients. A key focus is how the deposition of amyloid-β (Aβ), tau, and other metabolic proteins affects these vessels and their drainage efficiency.

Mahad's research explores the brain's lymphatic system, particularly the cervical lymphatics, as potential therapeutic targets to enhance lymphatic drainage in the brain. His goal is to optimize this drainage to improve metabolic delivery mechanisms, thereby reducing neurotoxicity, neuroinflammation, and neurodegeneration, ultimately enhancing cognitive outcomes.